Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis

Clinical Infectious Diseases

Volumn 33, Issue 8, 2001, Pages 1341-1346

  Sobel, J D ^a   Nyirjesy, P ^c   Brown, W ^b  

^a HARPER UNIVERSITY HOSPITAL   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE; PAROMOMYCIN; TINIDAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; NONHUMAN; PRIORITY JOURNAL; SKIN ULCER; TREATMENT FAILURE; TREATMENT INDICATION; TRICHOMONIASIS; VULVOVAGINITIS;

ADULT; ANIMALS; ANTITRICHOMONAL AGENTS; DRUG RESISTANCE; FEMALE; HUMANS; METRONIDAZOLE; MIDDLE AGED; PARASITIC SENSITIVITY TESTS; TINIDAZOLE; TREATMENT OUTCOME; TRICHOMONAS VAGINALIS; TRICHOMONAS VAGINITIS;

EID: 0035887675     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/323034     Document Type: Article

References (35)

1. Clinical and microbiological aspects of Trichomonas vaginalis
2. Trichomoniasis: Trends in diagnosis and management
3. Vaginal infections and Prematurity Study Group: Demographic and behavioral predictors of Trichomonas vaginalis infection among pregnant women
4. Vaginal Infections and Prematurity Study Group: Clinical and microbiological correlates of vaginal trichomoniasis during pregnancy
5. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: Results from a cohort study
6. Trichomonas vaginalis and amplifications of HIV-1 transmission
7. Trichomonosis in pregnant human immunodeficiency virus-infected and human immunodeficiency virus-uninfected Congolese women, prevalence, risk factors, and association with low birth weight
8. 1998 Guidelines for treatment of sexually transmitted diseases
9. Assay conditions and the demonstration of nitroimidazole resistance in Trichomonas foetus
10. In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis
11. Difficult to treat trichomoniasis: Results with paromomycin cream
12. In vitro drug susceptibility and doses of metronidazole required for cure in cases of refractory vaginal trichomoniasis
13. A study of the prevalence of resistant trichomoniasis and response to treatment in Brooklyn, NY
14. In vitro susceptibility of Trichomonas vaginalis to 50 antimicrobial agents
15. An investigation, by questionnaire, of cases of recalcitrant vaginal trichomoniasis seen in genito-urinary medicine clinics in the United Kingdom
16. Trichomoniasis as seen in a chronic vaginitis clinic
17. Managing trichomonal vaginitis refractory to conventional treatment with metronidazole
18. Persistent vaginitis caused by metronidazole-resistant trichomonas
19. Managing vaginal trichomoniasis resistant to high-dose metronidazole therapy
20. Intravenous therapy of metronidazole-resistant Trichomonas vaginalis
21. Metronidazole-resistant Trichomonas vaginalis, a case series, 1985-1998
22. In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis
23. Successful treatment of four patients with recalcitrant vaginal trichomoniasis with a combination of zinc sulfate douche and metronidazole therapy
24. Failure of mebendazole to cure trichomonal vaginitis resistant to metronidazole: Case reports
25. Providone-iodine in treatment of metronidazole-resistant Trichomonas vaginalis
26. Resolution of resistant vaginal trichomoniasis associated with the use of intravaginal nonoxynol-9
27. Arsenical pessaries in the successful elimination of metronidazole-resistant Trichomonas vaginalis
28. Tinidazole: A review of its antiprotozoal activity and therapeutic activity
29. Antibacterial activity and pharmaco-kinetics of nitroimidazoles: A review
30. Safety of nitroimidazoles
31. Metronidazole resistant Trichomonas vaginalis in Brisbane
32. Successful response of metronidazole-resistant trichomonal vaginitis to tinidazole
33. Cure of metronidazole- and tinidazole-resistant trichomoniasis with use of high-dose oral and intravaginal tinidazole
34. Paromomycin for nitroimidazole-resistant trichomonosis
35. Metronidazole-resistant vaginal trichomoniasis - An emerging problem